Veru Inc.
Clinical trials sponsored by Veru Inc., explained in plain language.
A biopharmaceutical company developing therapies for oncology and infectious diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Can an oral drug stop COVID-19 from turning deadly?
Disease control CompletedResearchers are testing an experimental oral drug called sabizabulin (VERU-111) in hospitalized adults with confirmed SARS-CoV-2 infection who are at high risk for acute respiratory distress syndrome (ARDS). Participants receive either sabizabulin plus standard care or a placebo …
Phase 3 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New pill aims to stop muscle loss during Weight-Loss drug boom
Disease control CompletedThis completed Phase 2 trial tested whether enobosarm, an experimental oral drug, can prevent muscle loss in older adults (aged 60+) who are taking GLP-1 receptor agonists like Wegovy for chronic weight management. The study enrolled 168 participants and measured changes in lean …
Phase 2 • Sponsor: Veru Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:57 UTC